Metraipolis › archive › dc_2c8f7bc6238f

Dihydromyricetin Remodels the Tumor Immune Microenvironment in Hepatocellular Carcinoma: Development and Validation of a Prognostic Model — Europe PMC PMID:41614774

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41614774
DOI
10.3390/cimb47121010
License (as archived)
solo-consultazione
Archived
2026-11-08T00:27:20.621Z
SHA-256 of the archived text
51949daef103272db22b7d5dddd36c0e4d6c982ddee5d76a92e0bf4a41822439
Stable URL of this page
https://metraipolis.com/documento/dc_2c8f7bc6238f

How to cite

Dihydromyricetin Remodels the Tumor Immune Microenvironment in Hepatocellular Carcinoma: Development and Validation of a Prognostic Model — Europe PMC PMID:41614774 — Europe PMC (en), https://europepmc.org/article/MED/41614774 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c8f7bc6238f (Metraipolis archive dc_2c8f7bc6238f, sha256 51949daef103272db22b7d5dddd36c0e4d6c982ddee5d76a92e0bf4a41822439)
BibTeX
@misc{dc2c8f7bc6238f,
  title = {Dihydromyricetin Remodels the Tumor Immune Microenvironment in Hepatocellular Carcinoma: Development and Validation of a Prognostic Model — Europe PMC PMID:41614774},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41614774},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c8f7bc6238f; sha256 51949daef103272db22b7d5dddd36c0e4d6c982ddee5d76a92e0bf4a41822439},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41614774. Agents can read the archived copy with the MCP tool read_document.